These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
882 related articles for article (PubMed ID: 15908846)
41. Impact of medical homes on quality, healthcare utilization, and costs. DeVries A; Li CH; Sridhar G; Hummel JR; Breidbart S; Barron JJ Am J Manag Care; 2012 Sep; 18(9):534-44. PubMed ID: 23009304 [TBL] [Abstract][Full Text] [Related]
42. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization. Sun P; Lian J Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064 [TBL] [Abstract][Full Text] [Related]
43. Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States. Jensen ET; Kappelman MD; Martin CF; Dellon ES Am J Gastroenterol; 2015 May; 110(5):626-32. PubMed ID: 25267327 [TBL] [Abstract][Full Text] [Related]
44. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Delea TE; Hagiwara M; Stanford RH; Stempel DA Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796 [TBL] [Abstract][Full Text] [Related]
45. The effects of multiple chronic conditions on hospitalization costs and utilization for ambulatory care sensitive conditions in the United States: a nationally representative cross-sectional study. Skinner HG; Coffey R; Jones J; Heslin KC; Moy E BMC Health Serv Res; 2016 Mar; 16():77. PubMed ID: 26926525 [TBL] [Abstract][Full Text] [Related]
46. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Vanelli M; Pedan A; Liu N; Hoar J; Messier D; Kiarsis K Clin Ther; 2009 Nov; 31(11):2628-52. PubMed ID: 20110007 [TBL] [Abstract][Full Text] [Related]
47. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
48. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization. Chastek B; Kulakodlu M; Valluri S; Seal B Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773 [TBL] [Abstract][Full Text] [Related]
49. Medication Adherence, Health Care Utilization, and Spending Among Privately Insured Adults With Chronic Conditions in the United States, 2010-2016. Gillespie CW; Morin PE; Tucker JM; Purvis L Am J Med; 2020 Jun; 133(6):690-704.e19. PubMed ID: 31987798 [TBL] [Abstract][Full Text] [Related]
50. Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder. Broder MS; Greene M; Chang E; Hartry A; Yan T; Yermilov I J Med Econ; 2019 Jan; 22(1):63-70. PubMed ID: 30376745 [TBL] [Abstract][Full Text] [Related]
51. Cost and utilization outcomes of opioid-dependence treatments. Baser O; Chalk M; Fiellin DA; Gastfriend DR Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950 [TBL] [Abstract][Full Text] [Related]
52. Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment. Broder MS; Greene M; Yan T; Chang E; Hartry A; Yermilov I Clin Ther; 2019 Feb; 41(2):221-232. PubMed ID: 30616973 [TBL] [Abstract][Full Text] [Related]
54. Medical costs of managed care in patients with type 2 diabetes mellitus. Bhattacharyya SK; Else BA Clin Ther; 1999 Dec; 21(12):2131-42. PubMed ID: 10645758 [TBL] [Abstract][Full Text] [Related]
55. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs. Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831 [TBL] [Abstract][Full Text] [Related]
56. Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia. Pilon D; Muser E; Lefebvre P; Kamstra R; Emond B; Joshi K BMC Psychiatry; 2017 Jun; 17(1):207. PubMed ID: 28576133 [TBL] [Abstract][Full Text] [Related]
57. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328 [TBL] [Abstract][Full Text] [Related]
58. Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder. Karve S; Markowitz M; Fu DJ; Lindenmayer JP; Wang CC; Candrilli SD; Alphs L Appl Health Econ Health Policy; 2014 Jun; 12(3):335-46. PubMed ID: 24756319 [TBL] [Abstract][Full Text] [Related]
59. Socioecologic factors as predictors of readiness for self-management and transition, medication adherence, and health care utilization among adolescents and young adults with chronic kidney disease. Javalkar K; Fenton N; Cohen S; Ferris M Prev Chronic Dis; 2014 Jul; 11():E117. PubMed ID: 25010999 [TBL] [Abstract][Full Text] [Related]
60. Patterns and costs of health care use of children with medical complexity. Cohen E; Berry JG; Camacho X; Anderson G; Wodchis W; Guttmann A Pediatrics; 2012 Dec; 130(6):e1463-70. PubMed ID: 23184117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]